|
|
|
|
|
| (11) | Liudijimo numeris | C 2340029 |
| (68) | Patento numeris | 2340029 |
| (21) | Paraiškos papildomos apsaugos liudijimui gauti numeris | PA 2015 011 |
| (22) | Paraiškos papildomos apsaugos liudijimui gauti padavimo data | 2015-03-04 |
| (41) | Paraiškos papildomos apsaugos liudijimui gauti paskelbimo data | 2015-04-27 |
| Liudijimo paskelbimo data | 2016-12-27 | |
| (24) | Liudijimo įsigaliojimo data | 2029-09-11 |
| (71) |
AbbVie Bahamas Ltd.,
Sassoon House Shirley Street & Victoria Avenue, New Providence, Nassau,
BS
Enanta Pharmaceuticals, Inc., 500 Arsenal Street, Watertown, MA 02472, US |
| (73) |
Enanta Pharmaceuticals, Inc.,
500 Arsenal Street, Watertown, MA 02472,
US
AbbVie Manufacturing Management Unlimited Company , 70 Sir John Rogerson's Quay, Dublin 2, IE |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (93) | EU/1/14.982, 2015-01-15 |
| (94) | 2030-01-19 |
| (95) | Paritapreviras |
| PAL panaikintas (nesumokėtas pagrindinio patento metų mokestis) | ||
| Panaikinimo data | 2025-09-10 |